Resilience Rewarded: Halep’s Redemption Journey Continues with…
“Thank you to the tournament for giving me this opportunity and I cannot wait to be back on court and competing.”
Halep, who won the French Open in 2018 and Wimbledon the following year, has not played competitively since the US Open in August 2022, having failed a doping test at Flushing Meadows.
Raducanu earns first-round Indian Wells win
Queen’s set to host first pre-Wimbledon women’s event since 1973
Halep tested positive for roxadustat – an anti-anaemia drug which stimulates the production of red blood cells in the body.
In May 2023, she was charged again by the International Tennis Integrity Agency (ITIA) – this time for irregularities in her athlete biological passport (ABP).
An independent tribunal ruled Halep had “intentionally” doped and gave her a four-year ban.
Halep appealed against the decision, and on Tuesday it was announced her case was partially upheld with Cas saying that “on the balance of probabilities” she had not taken roxadustat intentionally.
